Dipyridamole and Eye Disorders
Dipyridamole, also known as Persantin®, has a well-established safety profile and has been widely used for over 50 years to treat angina (a cardiovascular condition). Over the past 40 years, more than a dozen studies have been conducted on treating retinal eye disorders using dipyridamole in either pill form or via injection. The discovery of dipyridamole’s usefulness, in dilute eye drop form, to treat pinguecula, pterygium, and dry eye disease was a major breakthrough achieved in 2013.
MedInsight Launches Dipyridamole-dedicated Website
Following the discovery of the novel uses for dipyridamole eye drops, MedInsight launched DipyridamoleEyeDrops.org to educate ophthalmologists and patients about the research, use, and results of these drops.
In 2016, MedInsight published the results of its comprehensive review of all studies that examined dipyridamole’s use in treating eye disorders. As a result of this review, there has been a growing interest within the medical community to learn about the possibilities of using dipyridamole to treat eye disorders.
In parallel, MedInsight established an international Dipyridamole Eye Drop Research Collaborative to focus non-profit efforts on researching and advancing the use of dipyridamole eye drops.
December 2016 - New Site Launching
MedInsight is amalgamating the growing body of information, physician expertise, research, interviews, and patient feedback about dipyridamole's use for eye disorders into its new online platform, EyeDipyridamole.org. This new platform centralizes all the information needed by physicians, researchers, and patients. This platform also serves as the online home of the Dipyridamole Eye Drop Research Collaborative, which is leading the way in enabling knowledge of, and access to, dipyridamole eye drop treatments.